Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.
Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).
ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease
Diabetic kidney disease, and chronic kidney disease attributed to diabetes, occurs in 20-40% of patients with diabetes. Acute kidney injury is also one of the most significant complications associated with COVID-19. Point-of-care testing for albumin-creatinine ratio is a valuable tool for monitoring at-risk patients, especially in combination with other comorbid parameters, such as HbA1c and lipids.
ACR point-of-care testing for diabetic kidney disease
The objective of these guidelines from the World Health Organization (WHO) is to provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings.
WHO guidelines on second-and third-line medicines and type of insulin for blood glucose control in diabetes
Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.
Tackling drug-resistant infections globally: report and recommendations
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease (CKD) represents an update to the 2012 KDIGO guideline.
KDIGO clinical practice guidelines for the management of blood pressure in chronic kidney disease
This updated guidance from the Infectious Diseases Society of America (IDSA) aims to provide an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of COVID-19 molecular diagnostic testing.
IDSA guidelines on the diagnosis of COVID-19 molecular diagnostic testing
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis,
treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
IDSA clinical practice guideline update on the management of seasonal influenza
The International Diabetes Federation (IDF) published an updated version of its flagship ‘Diabetes Atlas’ in 2019. The atlas covers evidence on the impact of diabetes worldwide, including recommendations for testing and screening.
IDF testing and screening recommendations for diabetes from the 2019 Diabetes Atlas
The most recent “Clinical practice recommendations for managing type 2 diabetes in primary care guidelines” from the International Diabetes Federation (IDF) seeks to summarise current evidence around optimal management of people with type 2 diabetes.
IDF Clinical practice recommendations for type 2 diabetes in primary care
This clinical practice guideline from the American Heart Association (AHA) aims to give healthcare
providers consistent, clear, and evidence-based guidance for treating patients at risk for atherosclerotic
cardiovascular disease (ASCVD)
AHA cholesterol management guideline for healthcare practitioners
This clinical practice guideline from the American College of cardiology (ACC) and American Heart Association (AHA) provides recommendations applicable to patients with or at risk of developing cardiovascular disease (CVD).
ACC / AHA guideline on the primary prevention of cardiovascular disease
The guideline focusses on how clinicians can get the most efficacy and highest quality results from implementing best practices for POCT. The authors state that a quality assurance program is vital to managing reliability of POCT results.
AACC guidance on the management of point-of-care testing
Dr. Erna Lenters-Westra, from the Department of Clinical Chemistry, Isala, Zwolle, The Nederlands, talks about HbA1c point-of-care testing, its advantages and perfomance-wise perspective.
HbA1c point-of-care testing: performance and advantages
In this Q&A article, we look at some key questions healthcare professionals may have about point-of-care testing (POCT). We cover how POCT can be of value within specific clinical fields and in clinicians’ day-to-day roles, including discussion of how POCT may contribute to faster results, greater flexibility for patients and reduced antibiotic prescribing.
American Diabetes Association
Cuidado de la diabetes, 2020
Las normas de asistencia médica para la diabetes de la American Diabetes Association (ADA) describen las recomendaciones actuales de la práctica clínica para la atención de la diabetes, incluidos los objetivos de tratamiento, las herramientas para evaluar la calidad de la atención y las recomendaciones para el control del lipidograma (que se puede realizar a través del anál...
Enfermedades cardiovasculares y gestión del riesgo: normas de asistencia médica para la diabetes - 2020
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.In this article, we cover the below publication by Professor Cooke and co-authors
Respiratory tract infections in primary care: narrative review of CRP point-of-care testing and antibacterial use
Análisis de diagnóstico inmediato para mejorar la rentabilidad de los programas de chequeo de salud en la atención primaria
En nuestra serie de artículos destacados, echamos un vistazo a las publicaciones de especial relevancia para el análisis de diagnóstico inmediato (POCT), proporcionando resúmenes y comentarios de expertos sobre aspectos clave del documento y dentro del contexto más amplio de los sistemas POCT.
E...
Análisis de diagnóstico inmediato para mejorar la rentabilidad de los programas de chequeo de salud en la atención primaria
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
Point-of-care testing for reducing risk and improving management of infectious diseases
en
pt
Acceder ya
By using this site, you agree with our use of cookies.
